Skip to content
The Policy VaultThe Policy Vault

biologic immunomodulator agentsBlue Cross Blue Shield of Oklahoma

giant cell arteritis (GCA)

Initial criteria

  • Has tried and had an inadequate response to ONE systemic corticosteroid (e.g., prednisone, methylprednisolone) after at least a 7-day duration OR intolerance/hypersensitivity to ONE corticosteroid OR
  • FDA labeled contraindication to ALL systemic corticosteroids OR
  • Medication history indicates use of another biologic immunomodulator labeled or supported for GCA